Expanded access, also known as compassionate use, provides treatment options for patients with life-threatening diseases. When a patient's condition is so serious that no therapeutic options are available and the patient is not eligible for any clinical trials, expanded access allows the patient to qualify for investigational products, such as drugs or medical devices, which are not otherwise approved for use.
-
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
AUG 24, 2023 | 8:30 PM
C.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing, scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin r...
Our understanding of cancer mechanisms, genetics and complexities continues to expand rapidly. Without a streamlined, standardized and easy to understand organizational system to keep track...
JUN 22, 2023 | 11:00 AM
C.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
Globally, the hepatitis B virus is a major cause of mortality from infectious diseases. Around 250 million people suffer from chronic HBV infections, with the virus being responsible for ove...
APR 05, 2023 | 11:00 AM
C.E. CREDITS
Date: April 05, 2023 Time: 11:00am (NZDT) Date: April 04, 2023 Time: 4:00pm (PST), 7:00pm (EST), 1:00pm (CET) Polymerase chain reaction (PCR) technology-based testing method has been widely...
MAR 16, 2023 | 10:00 AM
C.E. CREDITS
Date: March 16, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) On Thursday March 16, COPAN Diagnostics is pleased to release presentations given at an event held during ASM Microbe 202...
NOV 09, 2022 | 8:15 AM
C.E. CREDITS
In this session, researchers, clinicians, and program implementers from four countries will address the disruption in continuity of care for PLHIV amid the COVID-19 pandemic and the conseque...
In light of the recent pandemic, less attention has been given to more common viruses like influenza. Scientists believe influenza may have been around before the 16th century and probably c...
Coronavirus Immunotherapeutic Consortium (CoVIC) is an international effort to conduct side-by-side, apples-to-apples comparisons of leading therapeutic antibody candidates against the SARS-...
Since its discovery in late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global pandemic of coronavirus disease 2019 (COVID-19). As of July of 2022, mo...
Date: August 16, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this session, researchers, clinicians, and program implementers from four countries will address the disruption in co...
Date: July 21, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) In light of the recent pandemic, less attention has been given to more common viruses like influenza. Scientists believe...
Genetics may influence experience with cannabis and CBD. With increased access to legal cannabis and the research community expanding their focus on the medicinal uses of cannabinoids, more...